Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

TonB-dependent uptake of β-lactam antibiotics in the opportunistic human pathogen Stenotrophomonas maltophilia.

Calvopiña K, Dulyayangkul P, Heesom KJ, Avison MB.

Mol Microbiol. 2019 Nov 27. doi: 10.1111/mmi.14434. [Epub ahead of print]

PMID:
31773806
2.

Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activate Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia.

Calvopiña K, Dulyayangkul P, Avison MB.

Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01524-19. doi: 10.1128/AAC.01524-19. [Epub ahead of print]

PMID:
31712205
3.

Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.

Findlay J, Gould VC, North P, Bowker KE, Williams MO, MacGowan AP, Avison MB.

J Antimicrob Chemother. 2019 Sep 20. pii: dkz397. doi: 10.1093/jac/dkz397. [Epub ahead of print]

PMID:
31538190
4.

CreC Sensor Kinase Activation Enhances Growth of Escherichia coli in the Presence of Cephalosporins and Carbapenems.

Takebayashi Y, Taylor ES, Whitwam S, Avison MB.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e00846-19. doi: 10.1128/AAC.00846-19. Print 2019 Nov.

PMID:
31451505
5.

Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates.

Cahill ST, Tyrrell JM, Navratilova IH, Calvopiña K, Robinson SW, Lohans CT, McDonough MA, Cain R, Fishwick CWG, Avison MB, Walsh TR, Schofield CJ, Brem J.

Biochim Biophys Acta Gen Subj. 2019 Apr;1863(4):742-748. doi: 10.1016/j.bbagen.2019.02.004. Epub 2019 Feb 7.

6.

Impact of OqxR loss of function on the envelope proteome of Klebsiella pneumoniae and susceptibility to antimicrobials.

Wan Nur Ismah WAK, Takebayashi Y, Findlay J, Heesom KJ, Avison MB.

J Antimicrob Chemother. 2018 Nov 1;73(11):2990-2996. doi: 10.1093/jac/dky293.

PMID:
30053019
7.

Disruption of mpl Activates β-Lactamase Production in Stenotrophomonas maltophilia and Pseudomonas aeruginosa Clinical Isolates.

Calvopiña K, Avison MB.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00638-18. doi: 10.1128/AAC.00638-18. Print 2018 Aug.

8.

Retraction for Fouhy et al., "Diffusible Signal Factor-Dependent Cell-Cell Signaling and Virulence in the Nosocomial Pathogen Stenotrophomonas maltophilia".

Fouhy Y, Scanlon K, Schouest K, Spillane C, Crossman L, Avison MB, Ryan RP, Dow JM.

J Bacteriol. 2018 May 24;200(12). pii: e00235-18. doi: 10.1128/JB.00235-18. Print 2018 Jun 15. No abstract available.

9.

Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates.

Hinchliffe P, Tanner CA, Krismanich AP, Labbé G, Goodfellow VJ, Marrone L, Desoky AY, Calvopiña K, Whittle EE, Zeng F, Avison MB, Bols NC, Siemann S, Spencer J, Dmitrienko GI.

Biochemistry. 2018 Mar 27;57(12):1880-1892. doi: 10.1021/acs.biochem.7b01299. Epub 2018 Mar 9.

10.

Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes.

Wan Nur Ismah WAK, Takebayashi Y, Findlay J, Heesom KJ, Jiménez-Castellanos JC, Zhang J, Graham L, Bowker K, Williams OM, MacGowan AP, Avison MB.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01814-17. doi: 10.1128/AAC.01814-17. Print 2018 Mar.

11.

Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired β-lactam resistance.

Jiménez-Castellanos JC, Wan Nur Ismah WAK, Takebayashi Y, Findlay J, Schneiders T, Heesom KJ, Avison MB.

J Antimicrob Chemother. 2018 Jan 1;73(1):88-94. doi: 10.1093/jac/dkx345.

PMID:
29029194
12.

Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates.

Calvopiña K, Hinchliffe P, Brem J, Heesom KJ, Johnson S, Cain R, Lohans CT, Fishwick CWG, Schofield CJ, Spencer J, Avison MB.

Mol Microbiol. 2017 Nov;106(3):492-504. doi: 10.1111/mmi.13831. Epub 2017 Sep 21.

13.

Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition.

Li GB, Brem J, Lesniak R, Abboud MI, Lohans CT, Clifton IJ, Yang SY, Jiménez-Castellanos JC, Avison MB, Spencer J, McDonough MA, Schofield CJ.

Chem Commun (Camb). 2017 May 30;53(43):5806-5809. doi: 10.1039/c7cc02394d.

14.

Structural basis for the inhibition of RecBCD by Gam and its synergistic antibacterial effect with quinolones.

Wilkinson M, Troman L, Wan Nur Ismah WA, Chaban Y, Avison MB, Dillingham MS, Wigley DB.

Elife. 2016 Dec 23;5. pii: e22963. doi: 10.7554/eLife.22963.

15.

Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates.

Brem J, Cain R, Cahill S, McDonough MA, Clifton IJ, Jiménez-Castellanos JC, Avison MB, Spencer J, Fishwick CW, Schofield CJ.

Nat Commun. 2016 Aug 8;7:12406. doi: 10.1038/ncomms12406.

16.

Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates.

Calvopiña K, Umland KD, Rydzik AM, Hinchliffe P, Brem J, Spencer J, Schofield CJ, Avison MB.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4170-5. doi: 10.1128/AAC.00371-16. Print 2016 Jul.

17.

Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniae.

Jiménez-Castellanos JC, Wan Ahmad Kamil WN, Cheung CH, Tobin MS, Brown J, Isaac SG, Heesom KJ, Schneiders T, Avison MB.

J Antimicrob Chemother. 2016 Jul;71(7):1820-5. doi: 10.1093/jac/dkw088. Epub 2016 Mar 29.

18.

Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition.

Brem J, van Berkel SS, Aik W, Rydzik AM, Avison MB, Pettinati I, Umland KD, Kawamura A, Spencer J, Claridge TD, McDonough MA, Schofield CJ.

Nat Chem. 2014 Dec;6(12):1084-90. doi: 10.1038/nchem.2110. Epub 2014 Nov 17.

PMID:
25411887
19.

Involvement of mutation in ampD I, mrcA, and at least one additional gene in β-lactamase hyperproduction in Stenotrophomonas maltophilia.

Talfan A, Mounsey O, Charman M, Townsend E, Avison MB.

Antimicrob Agents Chemother. 2013 Nov;57(11):5486-91. doi: 10.1128/AAC.01446-13. Epub 2013 Aug 26.

20.

Isolation of Salmonella mutants resistant to the inhibitory effect of Salicylidene acylhydrazides on flagella-mediated motility.

Martinez-Argudo I, Veenendaal AK, Liu X, Roehrich AD, Ronessen MC, Franzoni G, van Rietschoten KN, Morimoto YV, Saijo-Hamano Y, Avison MB, Studholme DJ, Namba K, Minamino T, Blocker AJ.

PLoS One. 2013;8(1):e52179. doi: 10.1371/journal.pone.0052179. Epub 2013 Jan 2.

21.

Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.

Gould VC, Okazaki A, Avison MB.

Antimicrob Agents Chemother. 2013 Jan;57(1):655-7. doi: 10.1128/AAC.01020-12. Epub 2012 Nov 12.

22.

Induction of beta-lactamase production in Aeromonas hydrophila is responsive to beta-lactam-mediated changes in peptidoglycan composition.

Tayler AE, Ayala JA, Niumsup P, Westphal K, Baker JA, Zhang L, Walsh TR, Wiedemann B, Bennett PM, Avison MB.

Microbiology. 2010 Aug;156(Pt 8):2327-35. doi: 10.1099/mic.0.035220-0. Epub 2010 Apr 29.

PMID:
20430811
23.

YieJ (CbrC) mediates CreBC-dependent colicin E2 tolerance in Escherichia coli.

Cariss SJ, Constantinidou C, Patel MD, Takebayashi Y, Hobman JL, Penn CW, Avison MB.

J Bacteriol. 2010 Jul;192(13):3329-36. doi: 10.1128/JB.01352-09. Epub 2010 Apr 23.

24.

The versatility and adaptation of bacteria from the genus Stenotrophomonas.

Ryan RP, Monchy S, Cardinale M, Taghavi S, Crossman L, Avison MB, Berg G, van der Lelie D, Dow JM.

Nat Rev Microbiol. 2009 Jul;7(7):514-25. doi: 10.1038/nrmicro2163. Review.

PMID:
19528958
25.

The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.

Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB.

Genome Biol. 2008 Apr 17;9(4):R74. doi: 10.1186/gb-2008-9-4-r74.

26.

Defining the growth conditions and promoter-proximal DNA sequences required for activation of gene expression by CreBC in Escherichia coli.

Cariss SJ, Tayler AE, Avison MB.

J Bacteriol. 2008 Jun;190(11):3930-9. doi: 10.1128/JB.00108-08. Epub 2008 Mar 28.

27.

Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.

Okazaki A, Avison MB.

Antimicrob Agents Chemother. 2008 Apr;52(4):1525-8. doi: 10.1128/AAC.01485-07. Epub 2008 Jan 22.

28.

Comparative genomic hybridization detects secondary chromosomal deletions in Escherichia coli K-12 MG1655 mutants and highlights instability in the flhDC region.

Hobman JL, Patel MD, Hidalgo-Arroyo GA, Cariss SJ, Avison MB, Penn CW, Constantinidou C.

J Bacteriol. 2007 Dec;189(24):8786-92. Epub 2007 Oct 5.

29.

Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia.

Fouhy Y, Scanlon K, Schouest K, Spillane C, Crossman L, Avison MB, Ryan RP, Dow JM.

J Bacteriol. 2007 Jul;189(13):4964-8. Epub 2007 Apr 27. Retraction in: J Bacteriol. 2018 May 24;200(12):.

30.

Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.

Okazaki A, Avison MB.

Antimicrob Agents Chemother. 2007 Jan;51(1):359-60. Epub 2006 Nov 6.

31.

nalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa.

Morita Y, Cao L, Gould VC, Avison MB, Poole K.

J Bacteriol. 2006 Dec;188(24):8649-54. Epub 2006 Oct 6.

32.
33.

New approaches to combating antimicrobial drug resistance.

Avison MB.

Genome Biol. 2005;6(13):243. Epub 2005 Dec 23. Review.

34.

Beta-lactam resistance and beta-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships.

Gould VC, Okazaki A, Avison MB.

J Antimicrob Chemother. 2006 Feb;57(2):199-203. Epub 2005 Dec 13.

PMID:
16352734
35.

Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.

Simm AM, Loveridge EJ, Crosby J, Avison MB, Walsh TR, Bennett PM.

Biochem J. 2005 May 1;387(Pt 3):585-90.

36.

Resistance determinants in strains of Clostridium difficile from two geographically distinct populations.

Bendle JS, James PA, Bennett PM, Avison MB, Macgowan AP, Al-Shafi KM.

Int J Antimicrob Agents. 2004 Dec;24(6):619-21.

PMID:
15555889
37.
38.
39.

Comparative genomics: digging for data.

Avison MB.

Methods Mol Biol. 2004;266:47-69.

PMID:
15148415
41.

Analysis of AmpC beta-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients.

Avison MB, Underwood S, Okazaki A, Walsh TR, Bennett PM.

J Antimicrob Chemother. 2004 Apr;53(4):584-91. Epub 2004 Mar 10.

PMID:
15014062
42.

Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA.

Wootton M, Avison MB, Bennett PM, Howe RA, MacGowan AP, Walsh TR.

J Antimicrob Chemother. 2004 Feb;53(2):406-7. Epub 2004 Jan 16. No abstract available.

PMID:
14729744
43.

Role of the 'cre/blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila beta-lactamase regulator, BlrA.

Avison MB, Niumsup P, Nurmahomed K, Walsh TR, Bennett PM.

J Antimicrob Chemother. 2004 Feb;53(2):197-202. Epub 2004 Jan 16.

PMID:
14729737
44.

Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of beta-lactamase expression in Aeromonas spp.

Niumsup P, Simm AM, Nurmahomed K, Walsh TR, Bennett PM, Avison MB.

J Antimicrob Chemother. 2003 Jun;51(6):1351-8. Epub 2003 May 13.

PMID:
12746371
45.

Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue.

Dempsey CE, Ueno S, Avison MB.

Biochemistry. 2003 Jan 21;42(2):402-9.

PMID:
12525167
46.
47.

Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia.

Avison MB, Higgins CS, Ford PJ, von Heldreich CJ, Walsh TR, Bennett PM.

J Antimicrob Chemother. 2002 Feb;49(2):387-9.

PMID:
11815585
48.

Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.

Avison MB, Bennett PM, Howe RA, Walsh TR.

J Antimicrob Chemother. 2002 Feb;49(2):255-60. Review.

PMID:
11815565
49.

A novel metallo-beta-lactamase, Mbl1b, produced by the environmental bacterium Caulobacter crescentus.

Simm AM, Higgins CS, Pullan ST, Avison MB, Niumsup P, Erdozain O, Bennett PM, Walsh TR.

FEBS Lett. 2001 Dec 14;509(3):350-4.

50.

Characterization, cloning and sequence analysis of the inducible Ochrobactrum anthropi AmpC beta-lactamase.

Higgins CS, Avison MB, Jamieson L, Simm AM, Bennett PM, Walsh TR.

J Antimicrob Chemother. 2001 Jun;47(6):745-54.

PMID:
11389106

Supplemental Content

Loading ...
Support Center